No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs371264032 |
chr8:11422595-11422596 |
Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Flanking Active TSS Active TSS
|
Chromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs116694331 |
chr8:11422665-11422666 |
Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Genic enhancers Flanking Active TSS Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs547764176 |
chr8:11422714-11422715 |
Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Genic enhancers Flanking Active TSS Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs571663267 |
chr8:11422744-11422745 |
Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Genic enhancers Flanking Active TSS Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs376036621 |
chr8:11422773-11422774 |
Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Genic enhancers Flanking Active TSS Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs542238382 |
chr8:11422779-11422780 |
Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Genic enhancers Flanking Active TSS Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs141751941 |
chr8:11422799-11422800 |
Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Genic enhancers Flanking Active TSS Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs575916632 |
chr8:11422813-11422814 |
Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs543729297 |
chr8:11422825-11422826 |
Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs28715042 |
chr8:11422832-11422833 |
Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
11 |
rs12549144 |
chr8:11422861-11422862 |
Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
12 |
rs4460336 |
chr8:11422894-11422895 |
Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs547525745 |
chr8:11422909-11422910 |
Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs189797548 |
chr8:11422910-11422911 |
Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs12549150 |
chr8:11422936-11422937 |
Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
16 |
rs566018696 |
chr8:11422943-11422944 |
Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs142946315 |
chr8:11422950-11422951 |
Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs184077001 |
chr8:11422951-11422952 |
Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs537339296 |
chr8:11422983-11422984 |
Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs111277816 |
chr8:11423015-11423016 |
Enhancers Bivalent Enhancer Genic enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs552877224 |
chr8:11423019-11423020 |
Enhancers Bivalent Enhancer Genic enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs570919278 |
chr8:11423032-11423033 |
Enhancers Bivalent Enhancer Genic enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs112059768 |
chr8:11423035-11423036 |
Enhancers Bivalent Enhancer Genic enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs189002997 |
chr8:11423065-11423066 |
Enhancers Bivalent Enhancer Genic enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs12541800 |
chr8:11423072-11423073 |
Enhancers Bivalent Enhancer Genic enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
26 |
rs368507600 |
chr8:11423077-11423078 |
Enhancers Bivalent Enhancer Genic enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs11985709 |
chr8:11423083-11423084 |
Enhancers Bivalent Enhancer Genic enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
28 |
rs568570528 |
chr8:11423092-11423093 |
Enhancers Bivalent Enhancer Genic enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs193038811 |
chr8:11423109-11423110 |
Enhancers Bivalent Enhancer Genic enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs562580547 |
chr8:11423123-11423124 |
Enhancers Bivalent Enhancer Genic enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs183763558 |
chr8:11423140-11423141 |
Enhancers Bivalent Enhancer Genic enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs12541802 |
chr8:11423142-11423143 |
Enhancers Bivalent Enhancer Genic enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
33 |
rs73197313 |
chr8:11423143-11423144 |
Enhancers Bivalent Enhancer Genic enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
34 |
rs35964286 |
chr8:11423156-11423157 |
Enhancers Bivalent Enhancer Genic enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs571110628 |
chr8:11423182-11423183 |
Enhancers Bivalent Enhancer Genic enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs541078035 |
chr8:11423274-11423275 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs554724981 |
chr8:11423275-11423276 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs376604102 |
chr8:11423282-11423283 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs576934045 |
chr8:11423288-11423289 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs547280968 |
chr8:11423293-11423294 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs565673363 |
chr8:11423335-11423336 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs541234767 |
chr8:11423352-11423353 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs10094362 |
chr8:11423381-11423382 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
44 |
rs375218435 |
chr8:11423385-11423386 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs530193436 |
chr8:11423391-11423392 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs548743691 |
chr8:11423433-11423434 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs34379689 |
chr8:11423434-11423435 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
48 |
rs755320 |
chr8:11423439-11423440 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
49 |
rs552549786 |
chr8:11423469-11423470 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs373793514 |
chr8:11423496-11423497 |
Bivalent Enhancer Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|